Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT) — BISCIT

Secondary Sclerosing Cholangitis Clinical Trial

Official title:
Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis - a Multicenter, Randomized Controlled, Parallel Group Trial

Status Terminated

Clinical Trial Summary

This is a randomized, open-label, controlled, parallel group, multicenter clinical trial. Patients with confirmed secondary sclerosing cholangitis (SSC-CIP) will be randomized either in the intervention group undergoing scheduled invasive evaluation of the biliary tract or in the control group treated with non-interventional standard of care to demonstrate that programmed endoscopic therapy compared to a conservative strategy reduces the occurrence of treatment failures.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05396755
Study type	Interventional
Source	Hannover Medical School
Contact
Status	Terminated
Phase	N/A
Start date	November 14, 2022
Completion date	September 14, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05233553` - SSC-COVID in Patients After COVID-19
Recruiting	`NCT02701166` - The Effect of Bezafibrate on Cholestatic Itch	Phase 3
Active, not recruiting	`NCT02545309` - Secondary Sclerosing Cholangitis in Critically Ill Patients